Literature DB >> 8267950

The molecular biology of tick-borne encephalitis virus. Review article.

F X Heinz1, C W Mandl.   

Abstract

Tick-borne encephalitis (TBE) virus is a member of the flavivirus genus and the family Flaviviridae. Like other flaviviruses such as yellow fever, Japanese encephalitis or the dengue viruses, it is an important human pathogen, endemic in many European countries, Russia and China. The disease can be effectively prevented by vaccination with a formalin-inactivated whole virus vaccine. In recent years major advances have been made in the understanding of the molecular biology of TBE virus, including the complete sequence analysis of the genomic RNA of the European and Far Eastern strains. As shown in these studies, the virion RNA contains a single long open reading frame that codes for the structural proteins at the 5' end and the nonstructural proteins at the 3' end. Co- and posttranslational cleavages by a viral and cellular proteases lead to the formation of individual viral proteins. The mature virion is composed of an isometric capsid surrounded by a lipid envelope with two membrane-associated proteins. One of these, protein E, is of paramount importance for several important viral functions, especially during the entry phase of the viral life cycle. Protein E is also responsible for the induction of a protective immune response. A detailed map of antigenic sites has been established and the structure of an anchor-free form of E is currently being investigated by X-ray diffraction analysis. Understanding the molecular basis of the functions of this protein together with the knowledge of its three-dimensional structure may provide clues for developing specific antiviral agents. Protein E has also been shown to be an important determinant of virulence, with single amino acid substitutions at selected sites leading to attenuation. Engineering of such mutations into cDNA clones to produce new recombinant viruses may open up new avenues for the development of live vaccines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267950     DOI: 10.1111/j.1699-0463.1993.tb00174.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  14 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum.

Authors:  Ivo C Lorenz; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  New Thoughts on Pathogenesis and Diagnosis of Encephalitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

4.  Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness.

Authors:  Ludek Eyer; Hirofumi Kondo; Darina Zouharova; Minato Hirano; James J Valdés; Memi Muto; Tomas Kastl; Shintaro Kobayashi; Jan Haviernik; Manabu Igarashi; Hiroaki Kariwa; Marketa Vaculovicova; Jiri Cerny; Rene Kizek; Andrea Kröger; Stefan Lienenklaus; Milan Dejmek; Radim Nencka; Martin Palus; Jiri Salat; Erik De Clercq; Kentaro Yoshii; Daniel Ruzek
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

5.  An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.

Authors:  Ludek Eyer; Antoine Nougairède; Marie Uhlířová; Jean-Sélim Driouich; Darina Zouharová; James J Valdés; Jan Haviernik; Ernest A Gould; Erik De Clercq; Xavier de Lamballerie; Daniel Ruzek
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

6.  Nucleoside inhibitors of tick-borne encephalitis virus.

Authors:  Luděk Eyer; James J Valdés; Victor A Gil; Radim Nencka; Hubert Hřebabecký; Michal Šála; Jiří Salát; Jiří Černý; Martin Palus; Erik De Clercq; Daniel Růžek
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

7.  Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression.

Authors:  G W Holzer; G Remp; G Antoine; M Pfleiderer; O M Enzersberger; W Emsenhuber; T Hämmerle; F Gruber; C Urban; F G Falkner; F Dorner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus.

Authors:  C W Mandl; H Holzmann; T Meixner; S Rauscher; P F Stadler; S L Allison; F X Heinz
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice.

Authors:  Pieter Leyssen; Christian Drosten; Marcus Paning; Nathalie Charlier; Jan Paeshuyse; Erik De Clercq; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 10.  [Tick-borne encephalitis].

Authors:  R Kaiser
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.